Gamified, Team-Oriented Education on iPads: Exploiting BCMA in Treatment of Multiple Myeloma

Activity Overview

Do not miss the first ever Multiple Myeloma Clinical OlympicsSM symposium preceding the ASH 2022! All prospective “Olympians” will join 1 of 3 country teams to compete in a series of clinical events by answering challenge questions (via provided iPads) related to the use of BCMA-targeted therapies in relapsed/refractory multiple myeloma. Individual learners earn points for their team by responding correctly to challenges in each event, after which the big screens will display the Gold, Silver, and Bronze medal winners. In the closing ceremonies of the Clinical OlympicsSM, the all-around winners from all 3 events will be announced, as well as the leaderboard for the top 15 individual performers. Join us for the expert-driven scientific exchange, but also for some friendly competition and fun!

December 9, 2022 12:00 PM CST. New Orleans Ernest N. Morial Convention Center. Register to Attend in-person or virtually.

REGISTER TO ATTEND

Target Audience

Medical oncologists, hematologists, hematologist-oncologists, pathologists, and oncology nurses

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Select an appropriate B cell maturation antigen (BCMA) targeted therapy among approved options for patients with relapsed/refractory (R/R) multiple myeloma (MM)
  • Integrate novel BCMA-targeted therapies into the treatment paradigm of R/R MM, with an emphasis on bispecific antibodies
  • Manage adverse events (AEs) associated with BCMA-directed therapies in patients with R/R MM

Activity Faculty

908-JagannathS

Sundar Jagannath, MD, FASCO

Chair, Multiple Myeloma
Professor, Medicine
Icahn School of Medicine at Mount Sinai
Director, Multiple Myeloma Center of Excellence
Tisch Cancer Center Institute
Editor-in-Chief, Clinical Lymphoma, Myeloma & Leukemia
Mount Sinai Hospital
New York, New York (USA)

908-HoffmanJ

James Hoffman, MD

Associate Professor, Clinical Medicine
Division of Myeloma (Hematology)
Sylvester Comprehensive Cancer Center (SCCC)
University of Miami
Miami, Florida (USA)

908-MateosM

María-Victoria Mateos, MD, PhD

Associate Professor, Hematology
Director, Myeloma Program
University Hospital of Salamanca
Salamanca, Spain (Europe)

Provider Statement

This activity is provided by RMEI Medical Education, LLC.

Supporter Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources